Jacinthe is an EIR and the Chief Scientific Officer of Stealth NewCo. Prior to this role, she occupied the role of Vice-President of Discovery Biology at Homology Medicines, Inc. focusing on gene therapy (gene transfer and vectorized antibodies) for liver, central nervous system and ophthalmology indications from target identification to IND. Before that, she worked at Amgen as a Principal Investigator in the Neuroscience group. Jacinthe did her postdoc at Harvard University in Molecular and Cell Biology and received her PhD from McGill University in Neurology and Neurosurgery, as well as a Master and undergraduate degrees in Biological Sciences from Université de Montréal.